{"name":"Niels Van Regenmortel","slug":"niels-van-regenmortel","ticker":"","exchange":"","domain":"","description":"Niels Van Regenmortel is a specialty pharmaceutical company focused on developing and marketing niche products. The company has two marketed drugs, primarily targeting specific patient populations with unique needs.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"NaCl 0.9% in Glucose 5% + 40mmol/L Potassium","genericName":"NaCl 0.9% in Glucose 5% + 40mmol/L Potassium","slug":"nacl-0-9-in-glucose-5-40mmol-l-potassium","indication":"Hypovolemia and dehydration requiring intravenous fluid replacement","status":"marketed"},{"name":"Glucion 5%","genericName":"Glucion 5%","slug":"glucion-5","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"NaCl 0.9% in Glucose 5% + 40mmol/L Potassium","genericName":"NaCl 0.9% in Glucose 5% + 40mmol/L Potassium","slug":"nacl-0-9-in-glucose-5-40mmol-l-potassium","phase":"marketed","mechanism":"This intravenous fluid replacement solution provides sodium chloride, glucose, and potassium to restore electrolyte balance and provide hydration and calories.","indications":["Hypovolemia and dehydration requiring intravenous fluid replacement","Hypokalemia or potassium depletion prevention during fluid therapy","Maintenance of electrolyte and fluid balance in hospitalized patients"],"catalyst":""},{"name":"Glucion 5%","genericName":"Glucion 5%","slug":"glucion-5","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}